贝泰妮拟5000万元参投金雨基金 投向多个医疗相关领域

Core Viewpoint - Betta Pharmaceuticals (300957.SZ) has signed a partnership agreement with Wuxi Jinyu Maowu Medical Health Industry Investment Partnership, committing 50 million yuan as a limited partner, acquiring a 5% stake in the fund [1] Investment Focus - The partnership will primarily invest in sectors such as consumer healthcare, national health quality improvement (including wellness, medical aesthetics, special medical foods, and functional foods), pharmaceuticals (including synthetic biology and innovative drugs), medical devices, supportive medical industries, and AI-driven pharmaceuticals [1]